Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection

Cell Cycle

Volumn 14, Issue 3, 2015, Pages 437-448

  Parameswaran, Balaji ^a,g   Chiang, Huai Chin ^a   Lu, Yunzhe ^a,h   Coates, Julia ^b   Deng, Chu Xia ^c   Baer, Richard ^d   Lin, Hui Kuan ^e   Li, Rong ^a   Paull, Tanya T ^f   Hu, Yanfen ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; Cell cycle; DNA double strand break repair; End resection; SCF

Indexed keywords

BRCA1 PROTEIN; CHECKPOINT KINASE 2; MRE11 PROTEIN; ATM PROTEIN; ATM PROTEIN, MOUSE; MULTIPROTEIN COMPLEX; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; REPLICATION FACTOR A;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL POPULATION; DNA BINDING; DOUBLE STRANDED DNA BREAK; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; FLOW CYTOMETRY; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; RECOMBINATION REPAIR; UBIQUITINATION; ANIMAL; DNA DAMAGE; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; PROTEIN STABILITY; TIME;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BRCA1 PROTEIN; CHECKPOINT KINASE 2; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; FIBROBLASTS; HEK293 CELLS; HUMANS; MICE; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; PROTEIN STABILITY; REPLICATION PROTEIN A; TIME FACTORS; UBIQUITINATION;

EID: 84923197173     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.972901     Document Type: Article

References (51)

1. Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 2005; 3: 531-539; PMID: 16254187; http://dx.doi.org/10.1158/1541-7786.MCR-05-0192
2. Huen MSY, Shirley MHS, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mole Cell Biol 2010; 11: 139-148; http://dx.doi.org/10.1038/nrm2831
3. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90: 425-435; PMID: 9267023; http://dx.doi.org/10.1016/S0092-8674(00)80503-6.
4. Cortez D, Wang Y, Qin J, Elledge SJ. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 1999; 286: 1162-1166; PMID: 10550055; http://dx.doi.org/10.1126/science.286.5442.1162.
5. Lee J-S, Collins KM, Brown AL, Lee C-H, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000; 404: 201-204; PMID: 10724175; http://dx.doi.org/10.1038/35004614.
6. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88: 265-275; PMID: 9008167; http://dx.doi.org/10.1016/S0092-8674(00)81847-4.
7. Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 2010; 11: 196-207; PMID: 20177395; http://dx.doi.org/10.1038/nrm2851.
8. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP. ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 2006; 8: 37-45; PMID: 16327781; http://dx.doi.org/10.1038/ncb1337.
9. Aylon Y, Liefshitz B, Kupiec M. The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. EMBO 2004; 23: 4868-4875; http://dx.doi.org/10.1038/sj.emboj.7600469.
10. Ira G, Pellicioli A, Balijja A, Wang X, Fiorani S, Carotenuto W, Liberi G, Bressan D, Wan L, Hollingsworth NM, et al. DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1. Nature 2004; 431: 1011-1017; PMID: 15496928; http://dx.doi.org/10.1038/nature02964.
11. Xu B, Kim S-T, Kastan MB. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol and Cellx Biol 2001; 21: 3445-3450; http://dx.doi.org/10.1128/MCB.21.10.3445-3450.2001.
12. Lengsfeld BM, Rattray AJ, Bhaskara V, Ghirlando R, Paull TT. Sae2 is an endonuclease that processes hairpin DNA cooperatively with the Mre11/Rad50/Xrs2 complex. Mol Cell 2007; 28: 638-651; PMID: 18042458; http://dx.doi.org/10.1016/j.molcel.2007. 11.001.
13. Zhu Z, Chung W-H, Shim EY, Lee SE, Ira G. Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell 2008; 134: 981-994; PMID: 18805091; http://dx.doi.org/10.1016/j.cell.2008.08.037.
14. Mimitou EP, Symington LS. Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing. Nature 2008; 455: 770-774; PMID: 18806779; http://dx.doi.org/10.1038/nature07312.
15. Hailong Wang, Li Y, Truong LN, Shi LZ, Hwang PY, He J, Do J, Cho MJ, Li H, Negrete A. CtIP Maintains Stability at Common Fragile Sites and Inverted Repeats by End Resection-Independent Endonuclease Activity. Mol Cell 2014; 54: 1012-1021; PMID: 24837675; http://dx.doi.org/10.1016/j.molcel.2014.04.012.
16. Nodar Makharashvili, Tubbs AT, Yang SH, Wang H, Barton O, Zhou Y, Deshpande RA, Lee JH, Lobrich M, Sleckman BP, et al. Catalytic and Noncatalytic Roles of the CtIP Endonuclease in Double-Strand Break End Resection. Mol Cell 2014; 54: 1022-1033; PMID: 24837676; http://dx.doi.org/10.1016/j.molcel. 2014.04.011.
17. Yun MH, Hiom K. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 2009; 459: 460-463; PMID: 19357644; http://dx.doi.org/10.1038/nature07955.
18. Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, Baer R, Lukas J, Jackson SP. Human CtIP promotes DNA end resection. Nature 2007; 450: 509-514; PMID: 17965729; http://dx.doi.org/10.1038/nature06337.
19. Yu X, Chen J. BRCA1-CtIP interaction requires phosphorylation of CtIP at Ser327 by CDK, which occurs in the late S and G2 phases of the cell cycle. Mol and Cell Biol 2004; 24: 9478-9486; http://dx.doi.org/10.1128/MCB.24.21.9478-9486.2004.
20. Limbo O, Chahwan C, Yamada Y, de Bruin RA, Wittenberg C, Russell P. Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to control double-strand break repair by homologous recombination. Mol Cell 2007; 28: 134-146; PMID: 17936710; http://dx.doi.org/10.1016/j.molcel.2007.09.009.
21. Huertas P, Jackson SP. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem 2009; 284: 9558-9565; PMID: 19202191; http://dx.doi.org/10.1074/jbc.M808906200.
22. Schlegel BP, Jodelka FM, Nunez R. BRCA1 promotes induction of ssDNA by ionizing radiation. Cancer Res 2006; 66: 5181-5189; PMID: 16707442; http://dx.doi.org/10.1158/0008-5472.CAN-05-3209.
23. Chen L, Nievera CJ, Lee AY-L, Wu X. Cell cycledependent complex formation of BRCA1-CtIP-MRN is important for DNA double-strand break repair. J Biol Chem 2008; 283: 7713-7720; PMID: 18171670; http://dx.doi.org/10.1074/jbc.M710245200.
24. Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M. Direct DNA binding by Brca1. Proc Natl Acad Sci U S A 2001; 98: 6086-6091; PMID: 11353843; http://dx.doi.org/10.1073/pnas.111125998.
25. Kim SM, Cao L, Li C, Xu X, Huber LJ, Chodosh LA, Deng CX. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphrylation site in Brca1. Mol Cell Biol 2004; 24: 9498-507.
26. Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, Chung JH, Powell SN, Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 2004; 24: 708-718; PMID: 14701743; http://dx.doi.org/10.1128/MCB.24.2.708-718.2004.
27. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999; 13: 1181-1189; PMID: 10323868; http://dx.doi.org/10.1101/gad.13.9.1181.
28. Frescas D, Pagano M. Deregulated proteolysis by the Fbox proteins SKP2 and b-TrCP: Tipping the scales of cancer. Nat Rev Cancer 2008; 8: 438-449; PMID: 18500245; http://dx.doi.org/10.1038/nrc2396.
29. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, et al. Targeting DNA repair defect in BRCA1 mutant cells as a therapeutic strategy. Nature 2005; 434: 917-921; PMID: 15829967; http://dx.doi.org/10.1038/nature03445.
30. Sun C, Zhang F, Xiang T, Chen Q, Pandita TK, Huang Y, Hu MC, Yang Q. Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers. Oncotarget 2014; 5: 3375-3385; PMID: 24831086.
31. Choi Y, Battelli C, Watson J, Liu J, Curtis J, Morse AN, Matulonis UA, Chowdhury D, Konstantinopoulos PA. Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells. Oncotarget 2014; 5: 2678-2687; PMID: 24798692.
32. Bonanno L, Costa C, Majem M, Sanchez JJ, Gimenez-Capitan A, Rodriguez I, Vergnenegre A, Massuti B, Favaretto A, Rugge M, et al. The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with firstline platinum-based chemotherapy. Oncotarget 2013; 4: 1572-1581; PMID: 24197907.
33. Sophie E, Polo Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: A focus on protein modifications. Genes Dev 2011; 25: 409-433; PMID: 21363960; http://dx.doi.org/10.1101/gad.2021311.
34. Lukas C, Falck J, Bartkova J, Bartek J, Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol 2003; 5: 255-260.
35. Ciccia A, Elledge SJ. The DNA Damage Response: Making It Safe to Play with Knives. Mol Cell 2010; 40: 179-204; PMID: 20965415; http://dx.doi.org/10.1016/j.molcel.2010.09.019.
36. Schaetzlein S, Kodandaramireddy NR, Ju Z, Lechel A, Stepczynska A, Lilli DR, Clark AB, Rudolph C, Kuhnel F, Wei K, et al. Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell 2007; 130: 863-877; PMID: 17803909; http://dx.doi.org/10.1016/j.cell.2007.08.029.
37. Stolz A, Ertych N, Kienitz A, Vogel C, Schneider V, Fritz B, Jacob R, Dittmar G, Weichert W, Petersen I, et al. The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol 2010; 12: 492-499; PMID: 20364141; http://dx.doi.org/10.1038/ncb2051.
38. Chabalier-Taste C, Racca C, Dozier C, Larminat F. BRCA1 is regulated by Chk2 in response to spindle damage. Biochim Biophys Acta 2008; 1783: 2223-2233; PMID: 18804494; http://dx.doi.org/10.1016/j.bbamcr.2008.08.006.
39. Lu Y, Li J, Cheng D, Parameswaran B, Zhang S, Jiang Z, Yew PR, Peng J, Ye Q, Hu Y. The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. J Biol Chem 2012; 287: 41014-41022; PMID: 23086937; http://dx.doi.org/10.1074/jbc.M112.407106.
40. Chan C-H, Morrow JK, Li CF, Gao Y, Jin G, Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013; 154: 556-568; PMID: 23911321; http://dx.doi.org/10.1016/j.cell.2013.06.048.
41. Buis J, Wu Y, Deng Y, Leddon J, Westfield G, Eckersdorff M, Sekiguchi JM, Chang S, Ferguson DO. Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation. Cell 2008; 135: 85-96; PMID: 18854157; http://dx.doi.org/10.1016/j.cell.2008.08.015.
42. Chapman JR, Barral P, Vannier JB, Borel V, Steger M, Tomas-Loba A, Sartori AA, Adams IR, Batista FD, Boulton SJ. RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection. Mol Cell 2013; 49: 858-871; PMID: 23333305; http://dx.doi.org/10.1016/j.molcel.2013.01.002.
43. Escribano-Diaz C, Orthwein A, Fradet-Turcotte A, Xing M, Young JT, Tkác J, Cook MA, Rosebrock AP, Munro M, Canny MD, et al. A Cell Cycle-Dependent Regulatory Circuit Composed of 53BP1-RIF1 and BRCA1-CtIP Controls DNA Repair Pathway Choice. Mol Cell 2013; 49: 872-883; PMID: 23333306; http://dx.doi.org/10.1016/j.molcel.2013.01.001.
44. Feng L, Fong K, Wang J, Wang W, Chen J. RIF1 counteracts BRCA1-mediated end resection during DNA repair. J Biol Chem 2013; 288: 11135-11143; PMID: 23486525; http://dx.doi.org/10.1074/jbc. M113.457440.
45. Wu J, Zhang X, Zhang L, Wu CY, Rezaeian AH, Chan CH, Li JM, Wang J, Gao Y, Han F, et al. Skp2 E3 Ligase Integrates ATM Activation and Homologous Recombination Repair by Ubiquitinating NBS1. Mole Cell 2012; 46: 1-11; PMID: 22500733; http://dx.doi.org/10.1016/j.molcel.2012.02.018.
46. Chapman JR, Sossick AJ, Boulton SJ, Jackson SP. BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair. J Cell Sci 2012; 125: 3529-3534; PMID: 22553214; http://dx.doi.org/10.1242/jcs.105353.
47. Butler LR, Densham RM, Jia J, Garvin AJ, Stone HR, Shah V, Weekes D, Festy F, Beesley J, Morris JR. The proteasomal de-ubiquitinating enzyme POH1 promotes the double-strand DNA break response. EMBO 2012; 31: 3918-3934; http://dx.doi.org/10.1038/emboj.2012.232.
48. Kakarougkas A, Ismail A, Katsuki Y, Freire R, Shibata A, Jeggo PA. Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection. Nucleic Acids Res 2013; 41: 10298-10311
49. Bunting SF, Callén E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010; 141: 243-254; PMID: 20362325; http://dx.doi.org/10.1016/j.cell.2010.03. 012.
50. Reczek CR, Szabolcs M, Stark JM, Ludwig T, Baer R. The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression. J Cell Biol 2013; 201: 693-707; PMID: 23712259; http://dx.doi.org/10.1083/jcb.201302145.
51. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001; 413: 316-322; PMID: 11565034; http://dx.doi.org/10.1038/35095076.